AIDS funds: Rwanda

Science

Volumn 330, Issue 6001, 2010, Pages 176-

  Asiimwe, Anita ^a   Rwiyereka, Angélique K ^b   Kaufman, Joan A ^b   Shepard, Donald S ^b  

^a Rwanda National HIV AIDS Control Commission National AIDS Commission   (Rwanda)

^b BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FUNDING; HEALTH CARE POLICY; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LETTER; PRIORITY JOURNAL; SOCIAL WELFARE; ACQUIRED IMMUNODEFICIENCY SYNDROME; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH; HEALTH CARE COST; HEALTH INSURANCE; RWANDA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; GLOBAL HEALTH; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INSURANCE, HEALTH; RWANDA;

EID: 77957738824     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Rwanda Ministry of Health, "National health accounts 2006" (2008).
2. National AIDS Commission, "National strategic plan 2009-2012" (2009).
3. UNAIDS, "Rwanda country progress report 2008-2009" (UNAIDS, Geneva, 2010).
4. Rwanda Ministry of Health, "Rwanda demographic and health survey 2000" (2001).
5. Rwanda Ministry of Health, "Rwanda demographic and health survey 2005" (2006).
6. Rwanda Ministry of Health, "Rwanda demographic and health survey 2007-2008" (2009).
7. M. C. Hogan et al., Lancet 375, 1967 (2010).